✦ LIBER ✦

Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting

✍ Scribed by T. Mittendorf; J. Smith-Palmer; L. Timlin; M. Happich; G. Goodall

Book ID: 109044859
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 559 KB
Volume: 11
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2009.01099.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The cost-effectiveness of insulin glargi

The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics

✍ P. Levin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Cost-effectiveness of biphasic insulin a

Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China

✍ James L. Palmer; Amélie Beaudet; Jeremy White; Juliette Plun-Favreau; Jayne Smit 📂 Article 📅 2010 🏛 Springer Healthcare Communications 🌐 English ⚖ 297 KB

Insulin therapy in type 2 diabetes patie

Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US

✍ J. A. Ray; W. J. Valentine; S. Roze; L. Nicklasson; D. Cobden; P. Raskin; A. Gar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Estimating the Long-Term Cost-Effectiven

Estimating the Long-Term Cost-Effectiveness of Exenatide in the United States: An Adjunctive Treatment for Type 2 Diabetes Mellitus

✍ Michael E. Minshall; Alan K. Oglesby; Matthew E. Wintle; William J. Valentine; S 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB

Meta-analysis of individual patient data

Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine

✍ P. D. Home; A. Fritsche; S. Schinzel; M. Massi-Benedetti 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB

Exenatide compared with long-acting insu

Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study

✍ M. J. Davies; R. Donnelly; A. H. Barnett; S. Jones; C. Nicolay; A. Kilcoyne 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 529 KB